Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2008 1
2009 5
2011 1
2012 3
2013 4
2014 4
2015 4
2016 2
2017 2
2018 7
2019 4
2020 9
2021 9
2022 15
2023 17
2024 11

Text availability

Article attribute

Article type

Publication date

Search Results

87 results

Results by year

Filters applied: . Clear all
Page 1
Nivolumab plus ipilimumab with or without live bacterial supplementation in metastatic renal cell carcinoma: a randomized phase 1 trial.
Dizman N, Meza L, Bergerot P, Alcantara M, Dorff T, Lyou Y, Frankel P, Cui Y, Mira V, Llamas M, Hsu J, Zengin Z, Salgia N, Salgia S, Malhotra J, Chawla N, Chehrazi-Raffle A, Muddasani R, Gillece J, Reining L, Trent J, Takahashi M, Oka K, Higashi S, Kortylewski M, Highlander SK, Pal SK. Dizman N, et al. Among authors: cui y. Nat Med. 2022 Apr;28(4):704-712. doi: 10.1038/s41591-022-01694-6. Epub 2022 Feb 28. Nat Med. 2022. PMID: 35228755 Free PMC article. Clinical Trial.
GSDME-dependent pyroptosis signaling pathway in diabetic nephropathy.
Li S, Feng L, Li G, Liu R, Ma C, Wang L, Gao A, Liu C, Cui Y, Jiang Z, Xie Y, Wu Q, Wang X, Yang L, Qi Z, Shen Y. Li S, et al. Among authors: cui y. Cell Death Discov. 2023 May 11;9(1):156. doi: 10.1038/s41420-023-01452-8. Cell Death Discov. 2023. PMID: 37169767 Free PMC article.
Phase I Trial of Ipatasertib Plus Carboplatin, Carboplatin/Paclitaxel, or Capecitabine and Atezolizumab in Metastatic Triple-Negative Breast Cancer.
Yuan Y, Yost SE, Cui Y, Ruel C, Murga M, Tang A, Martinez N, Schmolze D, Waisman J, Patel N, Vora L, Tumyan L, Bozoghlanian M, Stewart D, Frankel PH. Yuan Y, et al. Among authors: cui y. Oncologist. 2023 Jul 5;28(7):e498-e507. doi: 10.1093/oncolo/oyad026. Oncologist. 2023. PMID: 37023705 Free PMC article. Clinical Trial.
A Prospective, Multicenter, Observational Study of Surgical vs Nonsurgical Management for Pituitary Apoplexy.
Mamelak AN, Little AS, Gardner PA, Almeida JP, Recinos P, Soni P, Kshettry VR, Jane JA Jr, Barkhoudarian G, Kelly DF, Dodd R, Mukherjee D, Gersey ZC, Fukuhara N, Nishioka H, Kim EH, Litré CF, Sina E, Mazer MW, Cui Y, Bonert V. Mamelak AN, et al. Among authors: cui y. J Clin Endocrinol Metab. 2024 Jan 18;109(2):e711-e725. doi: 10.1210/clinem/dgad541. J Clin Endocrinol Metab. 2024. PMID: 37698130
Immunogenicity and efficacy of pembrolizumab and doxorubicin in a phase I trial for patients with metastatic triple-negative breast cancer.
Egelston CA, Guo W, Yost SE, Ge X, Lee JS, Frankel PH, Cui Y, Ruel C, Schmolze D, Murga M, Tang A, Martinez N, Karimi M, Somlo G, Lee PP, Waisman JR, Yuan Y. Egelston CA, et al. Among authors: cui y. Cancer Immunol Immunother. 2023 Sep;72(9):3013-3027. doi: 10.1007/s00262-023-03470-y. Epub 2023 Jun 9. Cancer Immunol Immunother. 2023. PMID: 37294342 Free PMC article. Clinical Trial.
Growth of the Social #RadOnc Network on Twitter.
Novak J, Cui Y, Frankel P, Sedrak MS, Glaser S, Li R, Motwani S, Kavanagh B, Amini A. Novak J, et al. Among authors: cui y. Pract Radiat Oncol. 2021 May-Jun;11(3):e263-e266. doi: 10.1016/j.prro.2020.09.008. Epub 2020 Sep 28. Pract Radiat Oncol. 2021. PMID: 32992029
Fibrinogen has chaperone-like activity.
Tang H, Fu Y, Cui Y, He Y, Zeng X, Ploplis VA, Castellino FJ, Luo Y. Tang H, et al. Among authors: cui y. Biochem Biophys Res Commun. 2009 Jan 16;378(3):662-7. doi: 10.1016/j.bbrc.2008.11.112. Epub 2008 Dec 4. Biochem Biophys Res Commun. 2009. PMID: 19059206 Free PMC article.
87 results